The U.S. Food and Drug Administration (FDA) recently proposed a rule that would require the “medical device system” to conduct risk analyses to manage cybersecurity risk throughout the lifecycle of a medical device and its connected network.
This is a test summary for a blog post
Jacqueline Lebo

Jacqueline Lebo is a RiskLens Risk Consultant
Recent Posts
FDA Proposes a “Probabilistic,” Scenario-based Approach for Medical Device Cyber Risk
[fa icon="calendar'] Jun 8, 2022 7:45:00 AM / by Jacqueline Lebo posted in Government
Content not found